Skip to main content
Top
Published in: Clinical and Translational Oncology 1/2024

27-06-2023 | Hemicolectomy | RESEARCH ARTICLE

Which is the appropriate surgical procedure for appendiceal adenocarcinoma: appendectomy, partial colectomy or right hemicolectomy?

Authors: Bochao Zhao, Zhicheng Ma, Jingchao Wang, Weiqiang Wang, Tao Yang, Kewei Meng

Published in: Clinical and Translational Oncology | Issue 1/2024

Login to get access

Abstract

Objective

The purpose of this study was to explore the appropriate surgical procedure and clinical decision for appendiceal adenocarcinoma.

Methods

A total of 1,984 appendiceal adenocarcinoma patients from 2004 to 2015 were retrospectively identified from the Surveillance, Epidemiology, and End Results (SEER) database. All patients were divided into three groups based on the extent of surgical resection: appendectomy (N = 335), partial colectomy (N = 390) and right hemicolectomy (N = 1,259). The clinicopathological features and survival outcomes of three groups were compared, and independent prognostic factors were assessed.

Results

The 5-year OS rates of patients who underwent appendectomy, partial colectomy and right hemicolectomy were 58.3%, 65.5% and 69.1%, respectively (right hemicolectomy vs appendectomy, P < 0.001; right hemicolectomy vs partial colectomy, P = 0.285; partial colectomy vs appendectomy, P = 0.045). The 5-year CSS rates of patients who underwent appendectomy, partial colectomy and right hemicolectomy were 73.2%, 77.0% and 78.7%, respectively (right hemicolectomy vs appendectomy, P = 0.046; right hemicolectomy vs partial colectomy, P = 0.545; partial colectomy vs appendectomy, P = 0.246). The subgroup analysis based on the pathological TNM stage indicated that there was no survival difference amongst three surgical procedures for stage I patients (5-year CSS rate: 90.8%, 93.9% and 98.1%, respectively). The prognosis of patients who underwent an appendectomy was poorer than that of those who underwent partial colectomy (5-year OS rate: 53.5% vs 67.1%, P = 0.005; 5-year CSS rate: 65.2% vs 78.7%, P = 0.003) or right hemicolectomy (5-year OS rate: 74.2% vs 53.23%, P < 0.001; 5-year CSS rate: 65.2% vs 82.5%, P < 0.001) for stage II disease. Right hemicolectomy did not show a survival advantage over partial colectomy for stage II (5-year CSS, P = 0.255) and stage III (5-year CSS, P = 0.846) appendiceal adenocarcinoma.

Conclusions

Right hemicolectomy may not always be necessary for appendiceal adenocarcinoma patients. An appendectomy could be sufficient for therapeutic effect of stage I patients, but limited for stage II patients. Right hemicolectomy was not superior to partial colectomy for advanced stage patients, suggesting omission of standard hemicolectomy might be feasible. However, adequate lymphadenectomy should be strongly recommended.
Literature
3.
go back to reference Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon Rectum. 1998;41(1):75–80.CrossRefPubMed Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon Rectum. 1998;41(1):75–80.CrossRefPubMed
4.
go back to reference Murphy EM, Farquharson SM, Moran BJ. Management of an unexpected appendiceal neoplasm. Br J Surg. 2006;93(7):783–92.CrossRefPubMed Murphy EM, Farquharson SM, Moran BJ. Management of an unexpected appendiceal neoplasm. Br J Surg. 2006;93(7):783–92.CrossRefPubMed
5.
go back to reference Benedix F, Reimer A, Gastinger I, Mroczkowski P, Lippert H, Kube R, et al. Primary appendiceal carcinoma–epidemiology, surgery and survival: results of a German multi-center study. Eur J Surg Oncol. 2010;36(8):763–71.CrossRefPubMed Benedix F, Reimer A, Gastinger I, Mroczkowski P, Lippert H, Kube R, et al. Primary appendiceal carcinoma–epidemiology, surgery and survival: results of a German multi-center study. Eur J Surg Oncol. 2010;36(8):763–71.CrossRefPubMed
6.
go back to reference Marmor S, Portschy PR, Tuttle TM, Virnig BA. The rise in appendiceal cancer incidence: 2000–2009. J Gastrointest Surg. 2015;19(4):743–50.CrossRefPubMed Marmor S, Portschy PR, Tuttle TM, Virnig BA. The rise in appendiceal cancer incidence: 2000–2009. J Gastrointest Surg. 2015;19(4):743–50.CrossRefPubMed
7.
go back to reference Whitfield CG, Amin SN, Garner JP. Surgical management of primary appendiceal malignancy. Colorectal Dis. 2012;14(12):1507–11.CrossRefPubMed Whitfield CG, Amin SN, Garner JP. Surgical management of primary appendiceal malignancy. Colorectal Dis. 2012;14(12):1507–11.CrossRefPubMed
8.
go back to reference Gahagan JV, Whealon MD, Phelan MJ, Mills S, Pigazzi A, Stamos MJ, et al. Lymph node positivity in appendiceal adenocarcinoma: should size matter. J Am Coll Surg. 2017;225(1):69–75.CrossRefPubMed Gahagan JV, Whealon MD, Phelan MJ, Mills S, Pigazzi A, Stamos MJ, et al. Lymph node positivity in appendiceal adenocarcinoma: should size matter. J Am Coll Surg. 2017;225(1):69–75.CrossRefPubMed
9.
go back to reference González-Moreno S, Sugarbaker PH. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg. 2004;91(3):304–11.CrossRefPubMed González-Moreno S, Sugarbaker PH. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg. 2004;91(3):304–11.CrossRefPubMed
10.
go back to reference Turaga KK, Pappas S, Gamblin TC. Right hemicolectomy for mucinous adenocarcinoma of the appendix: just right or too much. Ann Surg Oncol. 2013;20(4):1063–7.CrossRefPubMed Turaga KK, Pappas S, Gamblin TC. Right hemicolectomy for mucinous adenocarcinoma of the appendix: just right or too much. Ann Surg Oncol. 2013;20(4):1063–7.CrossRefPubMed
11.
go back to reference Nasseri YY, Zhu R, Sutanto C, Wai C, Cohen JS, Ellenhorn J, et al. Role of right hemicolectomy in patients with low-grade appendiceal mucinous adenocarcinoma. Am J Surg. 2019;218(6):1239–43.CrossRefPubMed Nasseri YY, Zhu R, Sutanto C, Wai C, Cohen JS, Ellenhorn J, et al. Role of right hemicolectomy in patients with low-grade appendiceal mucinous adenocarcinoma. Am J Surg. 2019;218(6):1239–43.CrossRefPubMed
12.
go back to reference Hata K, Tanaka N, Nomura Y, Wada I, Nagawa H. Early appendiceal adenocarcinoma. A review of the literature with special reference to optimal surgical procedures. J Gastroenterol. 2002;37(3):210–4.CrossRefPubMed Hata K, Tanaka N, Nomura Y, Wada I, Nagawa H. Early appendiceal adenocarcinoma. A review of the literature with special reference to optimal surgical procedures. J Gastroenterol. 2002;37(3):210–4.CrossRefPubMed
13.
go back to reference AlMasri SS, Hammad AY, Singhi AD, Paniccia A, Zureikat AH, Celebrezze JP Jr, et al. Appendectomy Is oncologically equivalent to right hemicolectomy for well-differentiated T1 appendiceal adenocarcinoma. Dis Colon Rectum. 2023;66(1):67–74.CrossRefPubMed AlMasri SS, Hammad AY, Singhi AD, Paniccia A, Zureikat AH, Celebrezze JP Jr, et al. Appendectomy Is oncologically equivalent to right hemicolectomy for well-differentiated T1 appendiceal adenocarcinoma. Dis Colon Rectum. 2023;66(1):67–74.CrossRefPubMed
14.
go back to reference Straker RJ 3rd, Grinberg SZ, Sharon CE, Shannon AB, Fraker DL, Shanmugan S, et al. Pathologic factors associated with low risk of lymph node metastasis in nonmucinous adenocarcinoma of the appendix. Ann Surg Oncol. 2022;29(4):2334–43.CrossRefPubMed Straker RJ 3rd, Grinberg SZ, Sharon CE, Shannon AB, Fraker DL, Shanmugan S, et al. Pathologic factors associated with low risk of lymph node metastasis in nonmucinous adenocarcinoma of the appendix. Ann Surg Oncol. 2022;29(4):2334–43.CrossRefPubMed
15.
go back to reference Shannon AB, Goldberg D, Song Y, Paulson EC, Roses RE, Fraker DL, et al. Predictors of lymph node metastases in patients with mucinous appendiceal adenocarcinoma. J Surg Oncol. 2020;122(3):399–406.CrossRefPubMed Shannon AB, Goldberg D, Song Y, Paulson EC, Roses RE, Fraker DL, et al. Predictors of lymph node metastases in patients with mucinous appendiceal adenocarcinoma. J Surg Oncol. 2020;122(3):399–406.CrossRefPubMed
16.
go back to reference Fleischmann I, Warschkow R, Beutner U, Marti L, Schmied BM, Steffen T. Improved survival after retrieval of 12 or more regional lymph nodes in appendiceal cancer. Eur J Surg Oncol. 2017;43(10):1876–85.CrossRefPubMed Fleischmann I, Warschkow R, Beutner U, Marti L, Schmied BM, Steffen T. Improved survival after retrieval of 12 or more regional lymph nodes in appendiceal cancer. Eur J Surg Oncol. 2017;43(10):1876–85.CrossRefPubMed
17.
go back to reference Yada H, Sawai K, Taniguchi H, Hoshima M, Katoh M, Takahashi T. Analysis of vascular anatomy and lymph node metastases warrants radical segmental bowel resection for colon cancer. World J Surg. 1997;21(1):109–15.CrossRefPubMed Yada H, Sawai K, Taniguchi H, Hoshima M, Katoh M, Takahashi T. Analysis of vascular anatomy and lymph node metastases warrants radical segmental bowel resection for colon cancer. World J Surg. 1997;21(1):109–15.CrossRefPubMed
18.
go back to reference Mo S, Zhou Z, Ying Z, Dai W, Xiang W, Han L, et al. Epidemiology of and prognostic factors for appendiceal carcinomas: a retrospective, population-based study. Int J Colorectal Dis. 2019;34(11):1915–24.CrossRefPubMed Mo S, Zhou Z, Ying Z, Dai W, Xiang W, Han L, et al. Epidemiology of and prognostic factors for appendiceal carcinomas: a retrospective, population-based study. Int J Colorectal Dis. 2019;34(11):1915–24.CrossRefPubMed
19.
go back to reference Day RW, Chang YH, Stucky CC, Gray R, Pockaj B, Wasif N. A predictive model for nodal metastases in patients with appendiceal cancers. Ann Surg. 2021;274(1):155–61.CrossRefPubMed Day RW, Chang YH, Stucky CC, Gray R, Pockaj B, Wasif N. A predictive model for nodal metastases in patients with appendiceal cancers. Ann Surg. 2021;274(1):155–61.CrossRefPubMed
20.
go back to reference Enblad M, Graf W, Birgisson H. Risk factors for appendiceal and colorectal peritoneal metastases. Eur J Surg Oncol. 2018;44(7):997–1005.CrossRefPubMed Enblad M, Graf W, Birgisson H. Risk factors for appendiceal and colorectal peritoneal metastases. Eur J Surg Oncol. 2018;44(7):997–1005.CrossRefPubMed
Metadata
Title
Which is the appropriate surgical procedure for appendiceal adenocarcinoma: appendectomy, partial colectomy or right hemicolectomy?
Authors
Bochao Zhao
Zhicheng Ma
Jingchao Wang
Weiqiang Wang
Tao Yang
Kewei Meng
Publication date
27-06-2023
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 1/2024
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-023-03259-6

Other articles of this Issue 1/2024

Clinical and Translational Oncology 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine